| For: | Marzuillo P, Guarino S, Esposito T, Di Sessa A, Orsini SI, Capalbo D, Miraglia del Giudice E, La Manna A. Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values. World J Clin Cases 2019; 7(9): 1021-1027 [PMID: 31123674 DOI: 10.12998/wjcc.v7.i9.1021] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i9/1021.htm |
| Number | Citing Articles |
| 1 |
Shuichiro Fujinaga, Yuji Tomii. Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome. Clinical and Experimental Nephrology 2020; 24(4) doi: 10.1007/s10157-020-01858-z
|
| 2 |
Erik N. Newman, Ryan B. Israelsen, Kayla Williamson, Elena W.Y. Hsieh. Hypogammaglobulinemia after rituximab therapy in children. Annals of Allergy, Asthma & Immunology 2022; 128(2) doi: 10.1016/j.anai.2021.10.028
|
| 3 |
Yuta Inoki, Koichi Kamei, Kentaro Nishi, Mai Sato, Masao Ogura, Akira Ishiguro. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome. Pediatric Nephrology 2022; 37(5) doi: 10.1007/s00467-021-05304-4
|
| 4 |
Tejas S. Athni, Sara Barmettler. Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab. Annals of Allergy, Asthma & Immunology 2023; 130(6) doi: 10.1016/j.anai.2023.01.018
|
| 5 |
Aleksandra Zurowska, Magdalena Drozynska-Duklas, Rezan Topaloglu, Antonia Bouts, Olivia Boyer, Mohan Shenoy, Marina Vivarelli, H. Alpay, R. Andersen, G. Ariceta, B. Atmış, U. S. Bayrakçı, B. Esrea, V. Baudouin, N. Bervina, E. Benetti, E. Berard, A. Bjerre, M. Christian, A. Couderc, J. Dehoorne, G. Deschenes, C. Dossier, R. Düşünsel, Z. Ekinci, F. Emma, L. Espinoza, A. Gianviti, M. Herrero Goñi, G. Guido, L. Ghio, J. Groothoff, D. Ö. Hacıhamdioğlu, M. Espino Hernández, A. Jankauskiene, M. Kagan, M. Kemper, M. Kovacevic, S. Kohl, R. T. Kramar, M. López-González, A. M. Aris, S. Maringhini, M. Marlais, M. Melgosa, A. Mitsioni, G. Montini, A. Moczulska, L. Murer, V. Obukhova, J. Oh, P. Ortega, Z. B. Özçakar, T. Ulinski, A. Pasini, T. Papalia, S. Paunova, A. Pena, C. Pecoraro, E. Petrosyan, L. Peruzzi, N. Printza, L. Prikhodina, C. Pietrement, S. Rittig, D. Rodrigo, N. Savenkova, M. Saraga, F. L. Sever, M. Schreuder, M. Szczepanska, V. Tasic, B. Tonshoff, K. Tullus, J. Vara, J. Vande Walle, E. Volokhina, J. Zieg, A. Waters, L. T. Weber, N. Webbe, M. Wasiak. Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey. Pediatric Nephrology 2023; 38(9) doi: 10.1007/s00467-023-05913-1
|
| 6 |
Cal H. Robinson, Sophia Gorgiev, Nowrin Aman, Tonny H. M. Banh, Josefina Brooke, Valentina Bruno, Vaneet Dhillon, Mackenzie Garner, Christoph Licht, Ashlene McKay, Damien Noone, Rachel Pearl, Seetha Radhakrishnan, Keisha Rasool, Nithiakishna Selvathesan, Chia Wei Teoh, Jovanka Vasilevska-Ristovska, Rulan S. Parekh. Hypogammaglobulinemia and B cell repopulation after rituximab in childhood nephrotic syndrome. Pediatric Nephrology 2026; doi: 10.1007/s00467-026-07450-z
|
| 7 |
Annaliesse Blincoe, Roxane Labrosse, Roshini S. Abraham. Acquired B-cell deficiency secondary to B-cell-depleting therapies. Journal of Immunological Methods 2022; 511 doi: 10.1016/j.jim.2022.113385
|
| 8 |
Iris M. Otani, Heather K. Lehman, Artemio M. Jongco, Lulu R. Tsao, Antoine E. Azar, Teresa K. Tarrant, Elissa Engel, Jolan E. Walter, Tho Q. Truong, David A. Khan, Mark Ballow, Charlotte Cunningham-Rundles, Huifang Lu, Mildred Kwan, Sara Barmettler. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. Journal of Allergy and Clinical Immunology 2022; 149(5) doi: 10.1016/j.jaci.2022.01.025
|
| 9 |
Claire Dossier, Stéphanie Bonneric, Véronique Baudouin, Thérésa Kwon, Benjamin Prim, Alexandra Cambier, Anne Couderc, Christelle Moreau, Georges Deschenes, Julien Hogan. Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children. Clinical Journal of the American Society of Nephrology 2023; 18(12) doi: 10.2215/CJN.0000000000000288
|
| 10 |
Yuji Tomii, Chisato Umeda, Tomohiko Nishino, Yoshitaka Watanabe, Koji Sakuraya, Shuichiro Fujinaga. Hypogammaglobulinemia and infection after administration of rituximab for steroid-dependent nephrotic syndrome. Japanese journal of pediatric nephrology 2020; 33(1) doi: 10.3165/jjpn.oa.2019.0156
|
| 11 |
Malgorzata Mikulska, Diana Averbuch. Infectious Complications in Biologic and Targeted Therapies. 2022; doi: 10.1007/978-3-031-11363-5_7
|
| 12 |
Lisa M. Ott de Bruin, Ingrid Pico-Knijnenburg, Monique M. van Ostaijen-ten Dam, Thomas J. Weitering, Dagmar Berghuis, Robbert G. M. Bredius, Arjan C. Lankester, Mirjam van der Burg. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect. International Journal of Molecular Sciences 2023; 24(21) doi: 10.3390/ijms242116012
|
| 13 |
Iris Otani, Roxane Labrosse, Daniel V. DiGiacomo, Sara Barmettler. Quality and Safety Intervention: Improving Care of Patients Undergoing B Cell–Targeted Therapies. The Journal of Allergy and Clinical Immunology: In Practice 2026; doi: 10.1016/j.jaip.2026.06.023
|
| 14 |
Roxane Labrosse, Sara Barmettler, Beata Derfalvi, Annaliesse Blincoe, Guilhem Cros, Jonathan Lacombe-Barrios, Julie Barsalou, Nancy Yang, Nora Alrumayyan, Jan Sinclair, Mei-Sing Ong, Carlos A. Camargo, Jolan Walter, Elie Haddad. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients. Journal of Allergy and Clinical Immunology 2021; 148(2) doi: 10.1016/j.jaci.2021.03.041
|
| 15 |
Qian Shen, Zheng-Kun Xia, Jia-Lu Liu, Lei-Lin Shao, Qiu-Xia Chen, Hui-Shan Wang, Ying Shen, Jian-Hua Mao, Xiao-Yun Jiang, Cui-Hua Liu, Xiao-Shan Shao, Xiao-Wen Wang, Xia Gao, Chong-Fan Zhang, Ai-Hua Zhang, Hong Xu. Clinical practice guidelines for rituximab treatment in children with steroid-sensitive nephrotic syndrome. World Journal of Pediatrics 2025; 21(8) doi: 10.1007/s12519-025-00957-9
|
| 16 |
Yuta Inoki, Kentaro Nishi, Mai Sato, Masao Ogura, Koichi Kamei. The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome. Pediatric Nephrology 2023; 38(2) doi: 10.1007/s00467-022-05652-9
|
| 17 |
Manuela Colucci, Martina Riganati, Federica Zotta, Antonio Gargiulo, Laura Massella, Barbara Ruggiero, Nicola Cotugno, Giulia Ricci, Paolo Palma, Francesco Emma, Marina Vivarelli. Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1736921
|
| 18 |
Daishi Hirano, Takuya Fujimaru, Mayumi Sako, Seiji Tanaka, Aya Inaba, Toru Uchimura, Koichi Kamei, Takuo Kubota, Toshiyuki Ohta, Takayuki Okamoto, Hiroshi Tanaka, Riku Hamada, Shuichi Ito. Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome. Nephrology Dialysis Transplantation 2025; 40(5) doi: 10.1093/ndt/gfae228
|